Mustang Bio, Inc. announced that it will receive $4,742,942 in funding on October 26, 2023. The company will issue convertible preferred stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.142 USD | -4.38% | -21.27% | -89.56% |
May. 15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.56% | 4.18M | |
+18.38% | 125B | |
+13.27% | 108B | |
-6.67% | 24.21B | |
+1.57% | 22.78B | |
-11.02% | 17.96B | |
-41.74% | 16.43B | |
-13.49% | 16.37B | |
+0.76% | 13.58B | |
+26.63% | 11.66B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it expects to receive $4.742942 million in funding